 |
市場調查報告書
商品編碼
2034858
全球生技藥品安全檢測市場：依產品、檢測類型、應用、最終用戶和地區分類－預測至2031年Biologics Safety Testing Market by Product (Kits, Reagents, Instruments), Services, Test Type (Mycoplasma, Sterility, Endotoxin, Bioburden), Product & Services by Application (Vaccines, mAbs, CGT), End User, Competition, Region - Global Forecast to 2031 |
||||||
價格
預計到 2031 年，全球生技藥品安全測試市場規模將達到 96.6 億美元，高於 2026 年的 55.7 億美元，預計在 2026 年至 2031 年的預測期內，複合年成長率將達到 11.6%。
預計在預測期內，全球生技藥品安全檢測市場將經歷強勁成長，這主要得益於生技藥品和生物相似藥研發管線的擴張，以及細胞和基因療法、mRNA產品等先進治療方法的成長。
| 調查範圍 | |
|---|---|
| 調查期 | 2026-2031 |
| 基準年 | 2025 |
| 預測期 | 2026-2031 |
| 目標單元 | 金額（10億美元） |
| 部分 | 按產品/服務、測試類型、應用程式、最終用戶、區域 |
| 目標區域 | 北美、歐洲、亞太地區、拉丁美洲、中東和非洲 |
基於公開行業數據的市場預測顯示，在生物製藥研發和生產的顯著擴張以及為確保產品品質而對嚴格安全測試日益成長的需求的推動下，市場將在2031年之前保持強勁成長。然而，先進測試設備的高成本、專業技術的匱乏以及區域監管差異預計仍將是限制市場進一步擴張的主要因素。
“到2025年，在生技藥品安全檢測市場中，檢測方法、試劑盒和試劑類產品將佔據最大的市場佔有率。”
以產品類別來看，生技藥品安全檢測市場大致可分為檢測方法、試劑盒和試劑以及儀器。預計到2025年，檢測方法、試劑盒和試劑將佔據生技藥品安全檢測市場最大的佔有率，這主要得益於它們在內毒素、黴漿菌、無菌性和病毒檢測等常規應用中的廣泛使用。這些產品易於使用、可靠性高，並且與自動化和高通量系統相容，使其成為任何實驗室不可或缺的工具。此外，它們的成本效益以及能夠提供快速且可重複的結果，也支撐了全球生物製藥公司、合約研究機構 (CRO) 和研究機構的穩定需求。
“到2025年，單株抗體和治療性蛋白質領域將在生技藥品安全檢測產品市場按應用分類中佔據最大的市場佔有率。”
按應用領域分類，全球生技藥品安全檢測產品市場可細分為疫苗、單株抗體和治療性蛋白質、細胞和基因治療產品、血液和血液製品以及其他應用。預計到2025年，單株抗體和治療性蛋白質領域將佔據生技藥品安全檢測產品市場的最大佔有率。這主要得益於這些製劑在治療慢性複雜疾病的廣泛應用。這些生技藥品研發管線的擴展、核准數量的增加以及大規模商業化生產，都要求進行嚴格的安全檢測。此外，嚴格的監管要求以及確保產品純度、效力和一致性的需求，進一步鞏固了該領域在全球市場的地位。
“預計從 2026 年到 2031 年，亞太地區生技藥品安全檢測市場的複合年成長率 (CAGR) 將最高。”
生技藥品安全檢測市場按地區分類為北美、歐洲、亞太、拉丁美洲以及中東和非洲。在預測期內，亞太地區預計將以最高的複合年成長率成長，這主要得益於生物製藥生產的擴張、生物製藥和生物相似藥的日益普及以及臨床試驗活動的活性化。此外，法規結構的完善也促進了市場成長，而三星生物製劑和藥明康德等區域性和全球性企業積極加強其生物製藥開發和安全檢測能力，也推動了市場發展。
本報告涵蓋的公司簡介列表
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Lonza
- FUJIFILM Corporation
- Sartorius AG
- F. Hoffmann- La Roche Ltd.
- Charles River Laboratories
- bioMerieux
- WuXi AppTec
- SGS Societe Generale de Surveillance SA
- Sotera Health
- Samsung Biologics
- GenScript
- Agilent Technologies, Inc.
- Syngene International Limited
- Eurofins Scientific
- Laboratory Corporation of America Holdings
- Bio-Rad Laboratories, Inc.
- QIAGEN
調查範圍
本研究報告從產品、測試類型、應用（產品和服務應用）、最終用戶（產品和服務的最終用戶）和地區等方面對生技藥品安全檢測市場進行了細分。研究範圍涵蓋影響生技藥品安全檢測市場成長的關鍵因素（促進因素、挑戰、機會和限制因素）的詳細資訊。報告深入分析了主要行業參與者，提供了有關其業務概況、產品系列、產品和服務核准和上市、夥伴關係關係、業務擴張、協議以及與生技藥品安全檢測市場相關的關鍵策略的見解。報告中還涵蓋了生技藥品安全檢測市場生態系統中主要參與者和新創企業的競爭考察。
購買本報告的主要好處
本報告透過提供生技藥品安全檢測市場及其細分市場最準確的銷售預測，為市場領導和新參與企業提供協助。報告也有助於相關人員深入了解競爭格局，更有效地進行市場定位，並制定合適的打入市場策略。此外，報告還幫助相關人員掌握市場趨勢，並提供關鍵市場促進因素、限制因素、機會和挑戰的資訊。
本報告深入分析了以下幾點：
- 本報告分析了影響生物製藥安全測試市場成長的因素，包括主要促進因素（生物製藥和生物類似藥研發管線不斷增加、監管要求日益嚴格和不斷變化、細胞和基因療法以及mRNA產品等先進治療方法的成長、CDMO的擴張以及測試外包的結構性轉變）、阻礙因素（先進測試設備高成本和缺乏下一代專業知識、區域越來越關注）、非關鍵的研究方法和非監管因素（先進測試設備成本和缺乏下一代專業知識、區域越來越關注）、非生技藥品方面的研究狀況（先進測試設備
- 產品開發/創新：生技藥品安全檢測市場新上市產品的詳細分析
- 市場發展：盈利市場的全面資訊－本報告分析了各地區的生技藥品安全檢測市場。
- 市場多元化：全面介紹生技藥品安全檢測市場的新產品、未開發地區、最新趨勢及投資狀況。
- 競爭分析：對 Thermo Fisher Scientific Inc.（美國）、Merck KGaA（德國）、Lonza（瑞士）、FUJIFILM Corporation（日本）、Sartorius AG（德國）、F. Hoffmann-La Roche Ltd.（瑞士）和 Charles River Laboratories（美國）等領先公司的市場佔有率、成長策略和產品陣容進行詳細評估。
目錄
第1章：引言
第2章執行摘要
第3章重要考察
第4章 市場概覽
- 市場動態
- 促進因素
- 抑制因子
- 機會
- 任務
- 未滿足的需求和未開發的領域
- 相互關聯的市場與跨產業機遇
- 一級/二級/三級公司的策略性舉措
第5章 產業趨勢
- 波特五力分析
- 宏觀經濟展望
- 價值鏈分析
- 生態系分析
- 價格分析
- 重要會議和活動
- 影響我們客戶公司業務的趨勢/變化
- 投資及資金籌措活動
- 美國關稅對生技藥品安全檢測市場的影響
第6章：技術進步、人工智慧的影響、專利、創新與未來應用
- 主要技術
- 鄰近技術
- 互補技術
- 技術/產品藍圖
- 專利分析
- 未來應用
- 人工智慧/生成式人工智慧對生技藥品安全檢測市場的影響
第7章：監理情勢與永續性舉措
- 當地法規和合規性
- 監管機構、政府機構和其他組織
- 法規結構
- 業界標準
- 對永續性和監管政策舉措的影響
- 認證、標籤檢視和環境標準
第8章：顧客趨勢與購買行為
- 決策流程
- 買方相關人員和採購評估標準
- 實施障礙和內部挑戰
- 各個終端用戶產業尚未滿足的需求
- 市場盈利
第9章：生技藥品安全檢測市場（依產品/服務分類）
- 服務
- 產品
第10章：生技藥品安全檢測市場（依檢測類型分類）
- 病毒安全測試
- 滅菌試驗
- 內毒素試驗
- 黴漿菌檢測
- 微生物污染測試
- 殘留HCP和DNA檢測
- 其他
第11章：生技藥品安全檢測產品市場（依應用領域分類）
- 單株抗體和治療性蛋白質
- 疫苗
- 細胞和基因療法產品
- 血液和血液製品
- 其他
第12章：生技藥品安全檢測服務市場（依應用領域分類）
- 單株抗體和治療性蛋白質的安全性研究
- 疫苗安全性測試
- 細胞和基因療法的安全性試驗
- 血液和血液製品的安全檢測
- 其他
第13章：生技藥品安全偵測產品市場（依最終用戶分類）
- 製藥和生物技術公司
- CRO、CDMO
- 學術和研究機構
- 其他
第14章：生技藥品安全檢測服務市場（依最終用戶分類）
- 製藥和生物技術公司
- 學術和研究機構
- 其他
第15章：生技藥品安全檢測市場（依地區分類）
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他
- 亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 其他
- 拉丁美洲
- 巴西
- 墨西哥
- 其他
- 中東
- 海灣合作理事會國家
- 其他
- 非洲
- 意識提升和開展合作，以促進廣泛採用
第16章 競爭格局
- 主要參與企業的策略/優勢
- 收入分析
- 市佔率分析
- 企業估值矩陣：主要公司，2025 年
- 公司估值矩陣：新創企業/中小企業，2025 年
- 企業估值和財務指標
- 品牌/產品比較分析
- 競爭格局
第17章：公司簡介
- 主要參與企業
- THERMO FISHER SCIENTIFIC INC.
- CHARLES RIVER LABORATORIES
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- F. HOFFMANN-LA ROCHE LTD.
- MERCK KGAA
- SARTORIUS AG
- LONZA
- FUJIFILM CORPORATION
- BIOMERIEUX
- MARAVAI LIFESCIENCES
- WUXI APPTEC
- SGS SOCIETE GENERALE DE SURVEILLANCE SA
- SOTERA HEALTH
- SAMSUNG BIOLOGICS
- GENSCRIPT
- AGILENT TECHNOLOGIES, INC.
- SYNGENE INTERNATIONAL LIMITED
- EUROFINS SCIENTIFIC
- BIO-RAD LABORATORIES, INC.
- QIAGEN
- 其他公司
- PROMEGA CORPORATION
- CATALENT, INC.
- ASSOCIATES OF CAPE COD, INC.
- CLEAN BIOLOGICS
- PATHOQUEST
- PACIFIC BIOLABS
- ARL BIO PHARMA, INC.
- FRONTAGE LABS
- CREATIVE BIOGENE
- ADVAXIA BIOLOGICS
第18章：調查方法
第19章附錄
Product Code: BT 3334
The global biologics safety testing market is estimated to reach USD 9.66 billion by 2031 from USD 5.57 billion in 2026, at a CAGR of 11.6% during the forecast period of 2026 to 2031. The global biologics safety testing market is projected to witness strong growth over the forecast period, supported by the rising biologics and biosimilars pipeline and the growth of advanced modalities such as cell & gene therapies and mRNA products.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2026-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | Offering, Test Type, Product Application, Service Application, Product End User, Service End User |
| Regions covered | North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa |
Market estimates from published industry sources indicate robust growth through 2031, driven by strong expansion in biologics development and manufacturing, as well as rising demand for stringent safety testing to ensure product quality. However, the high cost of advanced testing equipment, limited specialized expertise, and regulatory divergence across regions are expected to remain key factors restraining broader market expansion.
"The assays, kits, and reagents segment accounted for the largest share by product in the biologics safety testing market in 2025."
Based on product, the biologics safety testing market is broadly segmented into assays, kits & reagents, and instruments. In 2025, assays, kits, and reagents accounted for the largest share of the biologics safety testing market, driven by their widespread use in routine applications such as endotoxin, mycoplasma, sterility, and viral detection testing. Their ease of use, reliability, and compatibility with automated and high-throughput systems make them essential across laboratories. Additionally, their cost-effectiveness and ability to deliver rapid, reproducible results support consistent demand from biopharmaceutical companies, CROs, and research institutions globally.
"The monoclonal antibodies and therapeutic proteins segment accounted for the largest share of the biologics safety testing product applications market in 2025."
Based on application, the global biologics safety testing product market is segmented into vaccines, monoclonal antibodies & therapeutic proteins, cellular & gene therapy products, blood & blood products, and other applications. The monoclonal antibodies & therapeutic proteins segment accounted for the largest share of the biologics safety testing product market in 2025, driven by their extensive use in treating chronic and complex diseases. The growing pipeline, increasing approvals, and large-scale commercial production of these biologics require rigorous safety testing. Additionally, stringent regulatory requirements and the need to ensure product purity, potency, and consistency further contribute to the segment's market position globally.
"The Asia Pacific is growing at the highest CAGR in the biologics safety testing market from 2026 to 2031."
The biologics safety testing market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. During the forecast period, the Asia Pacific region is estimated to grow at the highest CAGR, supported by expanding biopharmaceutical manufacturing, increasing adoption of biologics and biosimilars, and rising clinical trial activity. Growth is further driven by improving regulatory frameworks, and the presence of key regional and global players such as Samsung Biologics and WuXi AppTec is actively strengthening biologics development and safety testing capabilities.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side - 70% and Demand Side - 30%
- By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
- By Designation: CXOs and Directors - 30%, Managers - 45%, and Others - 25%
- By Region: North America - 40%, Europe - 25%, Asia Pacific - 20%, Latin America - 10%, and the Middle East - 5%
List of Companies Profiled in the Report
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Lonza
- FUJIFILM Corporation
- Sartorius AG
- F. Hoffmann- La Roche Ltd.
- Charles River Laboratories
- bioMerieux
- WuXi AppTec
- SGS Societe Generale de Surveillance SA
- Sotera Health
- Samsung Biologics
- GenScript
- Agilent Technologies, Inc.
- Syngene International Limited
- Eurofins Scientific
- Laboratory Corporation of America Holdings
- Bio-Rad Laboratories, Inc.
- QIAGEN
Research Coverage
This research report categorizes the biologics safety testing market by offering, by test type, by application (product & service applications), by end user (product & service end users), and by region. The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints, influencing the growth of the biologics safety testing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product portfolio, key strategies such as product and service approvals and launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the biologics safety testing market. This report covers competitive analysis of top players and upcoming startups in the biologics safety testing market ecosystem.
Key Benefits of Buying the Report
The report will help market leaders/new entrants by providing the closest approximations of revenue for the overall biologics safety testing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business more effectively and develop suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide information on key market drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
- Analysis of key drivers (rising biologics and biosimilars pipeline, stringent and evolving regulatory requirements, growth of advanced modalities like cell & gene therapies and mRNA products, expansion of CDMOs and the structural shift toward outsourced testing), restraints (high cost of advanced testing equipment and limited specialized expertise, regulatory divergence across regions), opportunities (growing focus on next-generation therapeutics, the shift toward animal-free testing approaches) and challenges (assay standardization gap) influencing the growth of biologics safety testing market
- Product Development/Innovation: Detailed insights on newly launched products of the biologics safety testing market
- Market Development: Comprehensive information about lucrative markets - the report analyses the biologics safety testing market across varied regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the biologics safety testing market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Lonza (Switzerland), FUJIFILM Corporation (Japan), Sartorius AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Charles River Laboratories (US), among others
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS & EXCLUSIONS
- 1.3 MARKET SCOPE
- 1.3.1 MARKETS COVERED
- 1.3.2 YEARS CONSIDERED
- 1.3.3 CURRENCY CONSIDERED
- 1.4 STAKEHOLDERS
- 1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
- 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS SHAPING THE MARKET
- 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
- 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 BIOLOGICS SAFETY TESTING MARKET OVERVIEW
- 3.2 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING & REGION
- 3.3 BIOLOGICS SAFETY TESTING MARKET: GEOGRAPHIC SNAPSHOT
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Rising biologics and biosimilars pipeline
- 4.2.1.2 Stringent and evolving regulatory requirements
- 4.2.1.3 Growth of advanced modalities like cell & gene therapies and mRNA products
- 4.2.1.4 Rising demand for outsourced development/manufacturing and testing
- 4.2.2 RESTRAINTS
- 4.2.2.1 High cost of advanced testing equipment and limited specialized expertise
- 4.2.2.2 Regulatory divergence across regions
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Growing focus on next-generation therapeutics
- 4.2.3.2 Shift toward animal-free testing approaches
- 4.2.4 CHALLENGES
- 4.2.4.1 Assay standardization gap
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS AND WHITE SPACES
- 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 THREAT OF SUBSTITUTES
- 5.1.3 BARGAINING POWER OF BUYERS
- 5.1.4 BARGAINING POWER OF SUPPLIERS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.2 MACROECONOMIC OUTLOOK
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS AND FORECAST
- 5.2.3 TRENDS IN GLOBAL BIOLOGICS SAFETY TESTING MARKET
- 5.3 VALUE CHAIN ANALYSIS
- 5.4 ECOSYSTEM ANALYSIS
- 5.5 PRICING ANALYSIS
- 5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023-2025
- 5.5.2 INDICATIVE SELLING PRICE, BY REGION, 2025
- 5.6 KEY CONFERENCES & EVENTS
- 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.8 INVESTMENT/FUNDING ACTIVITY
- 5.9 IMPACT OF US TARIFFS-BIOLOGICS SAFETY TESTING MARKET
- 5.9.1 INTRODUCTION
- 5.9.2 KEY TARIFF RATES
- 5.9.3 PRICE IMPACT ANALYSIS
- 5.9.4 IMPACT ON COUNTRIES/REGIONS
- 5.9.4.1 North America
- 5.9.4.2 Europe
- 5.9.4.3 Asia Pacific
- 5.9.5 IMPACT ON END-USE INDUSTRIES
- 5.9.5.1 Pharmaceutical and biotechnology companies
- 5.9.5.2 CROs & CDMOs
- 5.9.5.3 Academic & Research Institutes
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
- 6.1 KEY TECHNOLOGIES
- 6.1.1 POLYMERASE CHAIN REACTION (PCR)
- 6.1.2 NEXT-GENERATION SEQUENCING (NGS)
- 6.2 ADJACENT TECHNOLOGIES
- 6.2.1 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY
- 6.3 COMPLEMENTARY TECHNOLOGIES
- 6.3.1 LAB-ON-A-CHIP (LOC) SYSTEMS
- 6.3.2 HIGH-CONTENT SCREENING (HCS)
- 6.4 TECHNOLOGY/PRODUCT ROADMAP
- 6.5 PATENT ANALYSIS
- 6.5.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR BIOLOGICS SAFETY TESTING PATENTS, 2015-2025
- 6.6 FUTURE APPLICATIONS
- 6.7 IMPACT OF AI/GEN AI ON BIOLOGICS SAFETY TESTING MARKET
- 6.7.1 TOP USE CASES AND MARKET POTENTIAL
- 6.7.2 CASE STUDIES OF AI IMPLEMENTATION IN BIOLOGICS SAFETY TESTING MARKET
- 6.7.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
- 6.7.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN BIOLOGICS SAFETY TESTING MARKET
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
- 7.1 REGIONAL REGULATIONS AND COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 REGULATORY FRAMEWORK
- 7.1.3 INDUSTRY STANDARDS
- 7.2 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
- 7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 KEY BUYING CRITERIA
- 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
- 8.5 MARKET PROFITABILITY
9 BIOLOGICS SAFETY TESTING MARKET, BY OFFERING
- 9.1 INTRODUCTION
- 9.2 SERVICES
- 9.2.1 VIRUS SAFETY TESTING SERVICES
- 9.2.1.1 Rising focus on development of advanced therapies to drive growth
- 9.2.2 STERILITY TESTING SERVICES
- 9.2.2.1 Need for sterility testing at each stage of drug development to propel growth
- 9.2.3 MYCOPLASMA TESTING SERVICES
- 9.2.3.1 Increasing focus on development of biologics and biosimilars to promote growth
- 9.2.4 ENDOTOXIN TESTING SERVICES
- 9.2.4.1 Stringent regulatory requirements to drive market
- 9.2.5 BIOBURDEN TESTING SERVICES
- 9.2.5.1 Rising adoption of advanced testing solutions for contamination risk mitigation to propel the growth
- 9.2.6 OTHER BST SERVICES
- 9.2.1 VIRUS SAFETY TESTING SERVICES
- 9.3 PRODUCTS
- 9.3.1 ASSAYS, KITS, AND REAGENTS
- 9.3.1.1 Detection kits
- 9.3.1.1.1 Expanding advanced biologics pipelines and faster QC workflows are lifting demand for high-sensitivity detection kits
- 9.3.1.2 Endotoxin testing reagents
- 9.3.1.2.1 Regulatory acceptance of recombinant methods and shift to simpler, animal-free QC workflows are accelerating demand for endotoxin testing reagents
- 9.3.1.3 Sterility testing media & kits
- 9.3.1.3.1 Rapid release needs and shift toward standardized aseptic QC strengthen demand for sterility testing media and kits
- 9.3.1.4 Bioburden enumeration
- 9.3.1.4.1 Stricter contamination control expectations and faster microbiology workflows drive demand for bioburden enumeration solutions
- 9.3.1.5 Other BST assays, kits, and reagents
- 9.3.1.1 Detection kits
- 9.3.2 INSTRUMENTS
- 9.3.2.1 Detection & imaging systems
- 9.3.2.1.1 Rapid molecular testing, automated microbiology, and standardized QC workflows are increasing the demand
- 9.3.2.2 Sequencing instruments
- 9.3.2.2.1 Wider adoption of NGS-based viral safety workflows and smaller, more accessible platforms support demand
- 9.3.2.3 Automated sterility testing systems
- 9.3.2.3.1 Shorter release timelines and wider adoption of rapid microbiology to drive growth
- 9.3.2.4 Other BST instruments
- 9.3.2.1 Detection & imaging systems
- 9.3.1 ASSAYS, KITS, AND REAGENTS
10 BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE
- 10.1 INTRODUCTION
- 10.2 VIRUS SAFETY TESTS
- 10.2.1 GROWING DEMAND FOR BIOLOGICS AND BIOSIMILARS TO DRIVE SEGMENT GROWTH
- 10.3 STERILITY TESTS
- 10.3.1 MANDATORY STERILITY TESTING AT EACH STAGE IN DRUG DEVELOPMENT AND PRODUCTION PROCESS TO PROMOTE SEGMENT GROWTH
- 10.4 ENDOTOXIN TESTS
- 10.4.1 GROWING R&D ACTIVITIES FOR DEVELOPMENT OF BIOLOGICS TO PROMOTE THE GROWTH OF THE SEGMENT
- 10.5 MYCOPLASMA TESTS
- 10.5.1 RISING CONCERN FOR CELL CULTURE CONTAMINATION TO DRIVE THE SEGMENT GROWTH
- 10.6 BIOBURDEN TESTS
- 10.6.1 GROWING CONCERNS FOR DRUG SAFETY STANDARDS HAVE INCREASED THE DEMAND FOR MICROBIOLOGICAL BIOBURDEN TESTING IN THE BIOLOGICS INDUSTRY
- 10.7 RESIDUAL HCP & DNA DETECTION TESTS
- 10.7.1 STRINGENT REGULATORY GUIDELINES FOR BIOLOGIC DRUG MANUFACTURING TO CONTRIBUTE TO THE SEGMENT GROWTH
- 10.8 OTHER TESTS
11 BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION
- 11.1 INTRODUCTION
- 11.2 MONOCLONAL ANTIBODIES & THERAPEUTIC PROTEINS
- 11.2.1 GROWING REGULATORY APPROVALS FOR MONOCLONAL ANTIBODIES TO CONTRIBUTE TO THE MARKET SHARE
- 11.3 VACCINES
- 11.3.1 EXPANDING VACCINE PLATFORM COMPLEXITY AND STRICTER GLOBAL QUALITY EXPECTATIONS TO DRIVE MARKET GROWTH
- 11.4 CELLULAR & GENE THERAPY PRODUCTS
- 11.4.1 GROWING PRODUCT MANUFACTURING COMPLEXITY IS ACCELERATING DEMAND
- 11.5 BLOOD & BLOOD PRODUCTS
- 11.5.1 GROWING DEMAND FOR BLOOD PRODUCTS TO PROMOTE MARKET GROWTH
- 11.6 OTHER APPLICATIONS
12 BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION
- 12.1 INTRODUCTION
- 12.2 MONOCLONAL ANTIBODY & THERAPEUTIC PROTEIN SAFETY TESTING
- 12.2.1 EXPANDING ANTIBODY PIPELINES AND RISING BIOSIMILAR MANUFACTURING ARE DRIVING GROWTH
- 12.3 VACCINE SAFETY TESTING
- 12.3.1 EXPANSION OF VACCINE SAFETY TESTING DRIVEN BY ADVANCED PLATFORMS AND REGULATORY STRINGENCY
- 12.4 CELLULAR & GENE THERAPY SAFETY TESTING
- 12.4.1 EXPANDING ADVANCED THERAPY MANUFACTURING AND TIGHTER STERILITY REQUIREMENTS TO ACCELERATE DEMAND
- 12.5 BLOOD & BLOOD PRODUCT SAFETY TESTING
- 12.5.1 PLASMA PRODUCT SAFETY REQUIREMENTS AND NEW ASSAY APPROVALS TO DRIVE MARKET GROWTH
- 12.6 OTHER APPLICATIONS
13 BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER
- 13.1 INTRODUCTION
- 13.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 13.2.1 RISING ADOPTION OF SAFETY TESTING PRODUCTS BY BIOPHARMA MANUFACTURERS
- 13.3 CROS & CDMOS
- 13.3.1 RISING OUTSOURCING OF BIOLOGICS DEVELOPMENT AND MANUFACTURING ACCELERATES MARKET GROWTH
- 13.4 ACADEMIC & RESEARCH INSTITUTES
- 13.4.1 EXPANDING TRANSLATIONAL BIOLOGICS RESEARCH AND EARLY-STAGE PLATFORM DEVELOPMENT DRIVES MARKET GROWTH
- 13.5 OTHER END USERS
14 BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER
- 14.1 INTRODUCTION
- 14.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 14.2.1 GROWING OUTSOURCING OF SAFETY TESTING SERVICES BY BIOPHARMA COMPANIES TO AID GROWTH
- 14.3 ACADEMIC & RESEARCH INSTITUTES
- 14.3.1 RISING TRANSLATIONAL RESEARCH IS DRIVING ADOPTION OF BIOLOGICS SAFETY TESTING SERVICES IN ACADEMIC INSTITUTES
- 14.4 OTHER END USERS
15 BIOLOGICS SAFETY TESTING MARKET, BY REGION
- 15.1 INTRODUCTION
- 15.2 NORTH AMERICA
- 15.2.1 US
- 15.2.1.1 Leading biopharma industry, federal funding, mature ecosystem, and biologics development activity to propel market growth
- 15.2.2 CANADA
- 15.2.2.1 Investments for expanding biomanufacturing capacity to propel market growth
- 15.2.1 US
- 15.3 EUROPE
- 15.3.1 GERMANY
- 15.3.1.1 Expansion initiatives by key market players to support market growth
- 15.3.2 UK
- 15.3.2.1 Emphasis on vaccine manufacturing and biotech R&D to drive market
- 15.3.3 FRANCE
- 15.3.3.1 Strong government funding driving biologics innovation and testing demand
- 15.3.4 ITALY
- 15.3.4.1 Manufacturing investment and strong R&D intensity support market growth
- 15.3.5 SPAIN
- 15.3.5.1 Growing expansion of biotech companies and increasing R&D expenditure to drive market
- 15.3.6 REST OF EUROPE
- 15.3.1 GERMANY
- 15.4 ASIA PACIFIC
- 15.4.1 CHINA
- 15.4.1.1 Rising biologics development driving market growth
- 15.4.2 JAPAN
- 15.4.2.1 Government initiatives and expansion of biopharma companies to boost market
- 15.4.3 INDIA
- 15.4.3.1 Expanding biologics capabilities and rising demand for targeted oncology therapies drive market growth
- 15.4.4 SOUTH KOREA
- 15.4.4.1 Growing focus on advancing bioprocessing sector to drive market
- 15.4.5 AUSTRALIA
- 15.4.5.1 Strong regulatory framework, clinical innovation, and global partnerships drive market growth
- 15.4.6 REST OF ASIA PACIFIC
- 15.4.1 CHINA
- 15.5 LATIN AMERICA
- 15.5.1 BRAZIL
- 15.5.1.1 Expanding biologics manufacturing investment and rising clinical development activity are driving market growth
- 15.5.2 MEXICO
- 15.5.2.1 Increasing government support for biopharmaceutical production to drive market
- 15.5.3 REST OF LATIN AMERICA
- 15.5.1 BRAZIL
- 15.6 MIDDLE EAST
- 15.6.1 GCC COUNTRIES
- 15.6.1.1 Saudi Arabia
- 15.6.1.1.1 Increasing healthcare expenditure and rising focus of key players on expansion to support growth
- 15.6.1.2 United Arab Emirates
- 15.6.1.2.1 Developing biopharma sector to drive market
- 15.6.1.3 Rest of GCC countries
- 15.6.1.1 Saudi Arabia
- 15.6.2 REST OF MIDDLE EAST
- 15.6.1 GCC COUNTRIES
- 15.7 AFRICA
- 15.7.1 RISING AWARENESS AND COLLABORATIVE INITIATIVES TO DRIVE ADOPTION
16 COMPETITIVE LANDSCAPE
- 16.1 INTRODUCTION
- 16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 16.3 REVENUE ANALYSIS
- 16.4 MARKET SHARE ANALYSIS
- 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 16.5.1 STARS
- 16.5.2 EMERGING LEADERS
- 16.5.3 PERVASIVE PLAYERS
- 16.5.4 PARTICIPANTS
- 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 16.5.5.1 Company footprint
- 16.5.5.2 Region footprint
- 16.5.5.3 Offering footprint
- 16.5.5.4 Test type footprint
- 16.5.5.5 Application footprint of companies
- 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 16.6.1 PROGRESSIVE COMPANIES
- 16.6.2 RESPONSIVE COMPANIES
- 16.6.3 DYNAMIC COMPANIES
- 16.6.4 STARTING BLOCKS
- 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
- 16.6.5.1 Detailed list of key startups/SMEs
- 16.6.5.2 Competitive benchmarking of key startups/SMEs
- 16.7 COMPANY VALUATION & FINANCIAL METRICS
- 16.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
- 16.9 COMPETITIVE SCENARIO
- 16.9.1 PRODUCT LAUNCHES
- 16.9.2 DEALS
- 16.9.3 EXPANSIONS
17 COMPANY PROFILES
- 17.1 MAJOR PALYER
- 17.1.1 THERMO FISHER SCIENTIFIC INC.
- 17.1.1.1 Business overview
- 17.1.1.2 Products/Services/Solutions offered
- 17.1.1.3 Recent developments
- 17.1.1.3.1 Service launches
- 17.1.1.3.2 Deals
- 17.1.1.3.3 Expansions
- 17.1.1.4 MnM view
- 17.1.1.4.1 Key strengths
- 17.1.1.4.2 Strategic choices
- 17.1.1.4.3 Weaknesses and competitive threats
- 17.1.2 CHARLES RIVER LABORATORIES
- 17.1.2.1 Business overview
- 17.1.2.2 Products/Services/Solutions offered
- 17.1.2.3 Recent developments
- 17.1.2.3.1 Product and service launches
- 17.1.2.3.2 Deals
- 17.1.2.4 MnM view
- 17.1.2.4.1 Key strengths
- 17.1.2.4.2 Strategic choices
- 17.1.2.4.3 Weaknesses and competitive threats
- 17.1.3 LABORATORY CORPORATION OF AMERICA HOLDINGS
- 17.1.3.1 Business overview
- 17.1.3.2 Products/Services/Solutions offered
- 17.1.3.3 Recent developments
- 17.1.3.3.1 Deals
- 17.1.3.3.2 Expansions
- 17.1.3.4 MnM view
- 17.1.3.4.1 Key strengths
- 17.1.3.4.2 Strategic choices
- 17.1.3.4.3 Weaknesses and competitive threats
- 17.1.4 F. HOFFMANN-LA ROCHE LTD.
- 17.1.4.1 Business overview
- 17.1.4.2 Products/Services/Solutions offered
- 17.1.4.3 Recent developments
- 17.1.4.3.1 Product launches
- 17.1.4.3.2 Expansions
- 17.1.4.4 MnM view
- 17.1.4.4.1 Key strengths
- 17.1.4.4.2 Strategic choices
- 17.1.4.4.3 Weaknesses and competitive threats
- 17.1.5 MERCK KGAA
- 17.1.5.1 Business overview
- 17.1.5.2 Products/Services/Solutions offered
- 17.1.5.3 Recent developments
- 17.1.5.3.1 Expansions
- 17.1.5.4 MnM view
- 17.1.5.4.1 Key strengths
- 17.1.5.4.2 Strategic choices
- 17.1.5.4.3 Weaknesses and competitive threats
- 17.1.6 SARTORIUS AG
- 17.1.6.1 Business overview
- 17.1.6.2 Products/Services/Solutions offered
- 17.1.6.3 Recent developments
- 17.1.6.3.1 Product launches
- 17.1.7 LONZA
- 17.1.7.1 Business overview
- 17.1.7.2 Products/Services/Solutions offered
- 17.1.7.3 Recent developments
- 17.1.7.3.1 Product launches
- 17.1.7.3.2 Deals
- 17.1.8 FUJIFILM CORPORATION
- 17.1.8.1 Business overview
- 17.1.8.2 Products/Services/Solutions offered
- 17.1.8.3 Recent developments
- 17.1.8.3.1 Expansions
- 17.1.9 BIOMERIEUX
- 17.1.9.1 Business overview
- 17.1.9.2 Products/Services/Solutions offered
- 17.1.9.3 Recent developments
- 17.1.9.3.1 Product launches
- 17.1.9.3.2 Deals
- 17.1.10 MARAVAI LIFESCIENCES
- 17.1.10.1 Business overview
- 17.1.10.2 Products/Services/Solutions offered
- 17.1.10.3 Recent developments
- 17.1.10.3.1 Deals
- 17.1.11 WUXI APPTEC
- 17.1.11.1 Business overview
- 17.1.11.2 Products/Services/Solutions offered
- 17.1.12 SGS SOCIETE GENERALE DE SURVEILLANCE SA
- 17.1.12.1 Business overview
- 17.1.12.2 Products/Services/Solutions offered
- 17.1.12.3 Recent developments
- 17.1.12.3.1 Service launches
- 17.1.12.3.2 Expansions
- 17.1.13 SOTERA HEALTH
- 17.1.13.1 Business overview
- 17.1.13.2 Products/Services/Solutions offered
- 17.1.13.3 Recent developments
- 17.1.13.3.1 Service launches
- 17.1.13.3.2 Expansions
- 17.1.14 SAMSUNG BIOLOGICS
- 17.1.14.1 Business overview
- 17.1.14.2 Products/Services/Solutions offered
- 17.1.14.3 Recent developments
- 17.1.14.3.1 Deals
- 17.1.14.3.2 Expansions
- 17.1.15 GENSCRIPT
- 17.1.15.1 Business overview
- 17.1.15.2 Products/Services/Solutions offered
- 17.1.16 AGILENT TECHNOLOGIES, INC.
- 17.1.16.1 Business overview
- 17.1.16.2 Products/Services/Solutions offered
- 17.1.17 SYNGENE INTERNATIONAL LIMITED
- 17.1.17.1 Business overview
- 17.1.17.2 Products/Services/Solutions offered
- 17.1.18 EUROFINS SCIENTIFIC
- 17.1.18.1 Business overview
- 17.1.18.2 Products/Services/Solutions offered
- 17.1.18.3 Recent developments
- 17.1.18.3.1 Service launches
- 17.1.18.3.2 Expansions
- 17.1.19 BIO-RAD LABORATORIES, INC.
- 17.1.19.1 Business overview
- 17.1.19.2 Products/Services/Solutions offered
- 17.1.19.3 Recent developments
- 17.1.19.3.1 Product launches
- 17.1.19.3.2 Deals
- 17.1.20 QIAGEN
- 17.1.20.1 Business overview
- 17.1.20.2 Products/Services/Solutions offered
- 17.1.20.3 Recent developments
- 17.1.20.3.1 Product launches
- 17.1.1 THERMO FISHER SCIENTIFIC INC.
- 17.2 OTHER PLAYERS
- 17.2.1 PROMEGA CORPORATION
- 17.2.2 CATALENT, INC.
- 17.2.3 ASSOCIATES OF CAPE COD, INC.
- 17.2.4 CLEAN BIOLOGICS
- 17.2.5 PATHOQUEST
- 17.2.6 PACIFIC BIOLABS
- 17.2.7 ARL BIO PHARMA, INC.
- 17.2.8 FRONTAGE LABS
- 17.2.9 CREATIVE BIOGENE
- 17.2.10 ADVAXIA BIOLOGICS
18 RESEARCH METHODOLOGY
- 18.1 RESEARCH DATA
- 18.1.1 SECONDARY DATA
- 18.1.2 PRIMARY DATA
- 18.2 MARKET ESTIMATION METHODOLOGY
- 18.2.1 MARKET SIZE ESTIMATION
- 18.2.2 INSIGHTS OF PRIMARY EXPERTS
- 18.2.3 TOP-DOWN APPROACH
- 18.3 MARKET GROWTH RATE PROJECTIONS
- 18.4 MARKET BREAKDOWN AND DATA TRIANGULATION
- 18.5 RESEARCH ASSUMPTIONS
- 18.6 RESEARCH LIMITATIONS
- 18.7 RISK ANALYSIS
19 APPENDIX
- 19.1 DISCUSSION GUIDE
- 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 19.3 CUSTOMIZATION OPTIONS
- 19.4 RELATED REPORTS
- 19.5 AUTHOR DETAILS
List of Tables
- TABLE 1 BIOLOGICS SAFETY TESTING MARKET: IMPACT ANALYSIS
- TABLE 2 BIOLOGICS SAFETY TESTING MARKET: PORTER'S FIVE FORCES ANALYSIS
- TABLE 3 BIOLOGICS SAFETY TESTING MARKET: ROLE IN ECOSYSTEM
- TABLE 4 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2023-2025 (USD)
- TABLE 5 INDICATIVE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2025
- TABLE 6 BIOLOGICS SAFETY TESTING MARKET: KEY CONFERENCES & EVENTS, 2026-2027
- TABLE 7 US-ADJUSTED RECIPROCAL TARIFF RATES
- TABLE 8 APPLICATIONS OF PCR IN BIOLOGICS SAFETY TESTING
- TABLE 9 INDICATIVE LIST OF PATENTS IN BIOLOGICS SAFETY TESTING MARKET, 2025
- TABLE 10 CASE STUDIES OF AI IMPLEMENTATION IN BIOLOGICS SAFETY TESTING MARKET
- TABLE 11 CLIENT'S READINESS TO ADOPT GENERATIVE AI IN BIOLOGICS SAFETY TESTING MARKET
- TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 15 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 16 COUNTRY-WISE REGULATORY SCENARIO FOR BIOLOGICS SAFETY TESTING MANUFACTURERS
- TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
- TABLE 18 KEY BUYING CRITERIA, BY END USER
- TABLE 19 BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 20 BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 21 BIOLOGICS SAFETY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 22 NORTH AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 23 EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 24 ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 25 LATIN AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 26 MIDDLE EAST: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 27 GCC COUNTRIES: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 28 VIRUS SAFETY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 29 NORTH AMERICA: VIRUS SAFETY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 30 EUROPE: VIRUS SAFETY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 31 ASIA PACIFIC: VIRUS SAFETY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 32 LATIN AMERICA: VIRUS SAFETY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 33 MIDDLE EAST: VIRUS SAFETY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 34 GCC COUNTRIES: VIRUS SAFETY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 35 STERILITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 36 NORTH AMERICA: STERILITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 37 EUROPE: STERILITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 38 ASIA PACIFIC: STERILITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 39 LATIN AMERICA: STERILITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 40 MIDDLE EAST: STERILITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 41 GCC COUNTRIES: STERILITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 42 MYCOPLASMA TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 43 NORTH AMERICA: MYCOPLASMA TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 44 EUROPE: MYCOPLASMA TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 45 ASIA PACIFIC: MYCOPLASMA TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 46 LATIN AMERICA: MYCOPLASMA TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 47 MIDDLE EAST: MYCOPLASMA TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 48 GCC COUNTRIES: MYCOPLASMA TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 49 ENDOTOXIN TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 50 NORTH AMERICA: ENDOTOXIN TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 51 EUROPE: ENDOTOXIN TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 52 ASIA PACIFIC: ENDOTOXIN TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 53 LATIN AMERICA: ENDOTOXIN TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 54 MIDDLE EAST: ENDOTOXIN TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 55 GCC COUNTRIES: ENDOTOXIN TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 56 BIOBURDEN TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 57 NORTH AMERICA: BIOBURDEN TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 58 EUROPE: BIOBURDEN TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 59 ASIA PACIFIC: BIOBURDEN TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 60 LATIN AMERICA: BIOBURDEN TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 61 MIDDLE EAST: BIOBURDEN TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 62 GCC COUNTRIES: BIOBURDEN TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 63 OTHER BST SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 64 NORTH AMERICA: OTHER BST SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 65 EUROPE: OTHER BST SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 66 ASIA PACIFIC: OTHER BST SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 67 LATIN AMERICA: OTHER BST SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 68 MIDDLE EAST: OTHER BST SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 69 GCC COUNTRIES: OTHER BST SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 70 BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 71 BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 72 NORTH AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 73 EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 74 ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 75 LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 76 MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 77 GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 78 BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 79 BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 80 NORTH AMERICA: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 81 EUROPE: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 82 ASIA PACIFIC: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 83 LATIN AMERICA: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 84 MIDDLE EAST: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 85 GCC COUNTRIES: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 86 DETECTION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 87 NORTH AMERICA: DETECTION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 88 EUROPE: DETECTION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 89 ASIA PACIFIC: DETECTION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 90 LATIN AMERICA: DETECTION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 91 MIDDLE EAST: DETECTION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 92 GCC COUNTRIES: DETECTION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 93 ENDOTOXIN TESTING REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 94 NORTH AMERICA: ENDOTOXIN TESTING REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 95 EUROPE: ENDOTOXIN TESTING REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 96 ASIA PACIFIC: ENDOTOXIN TESTING REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 97 LATIN AMERICA: ENDOTOXIN TESTING REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 98 MIDDLE EAST: ENDOTOXIN TESTING REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 99 GCC COUNTRIES: ENDOTOXIN TESTING REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 100 STERILITY TESTING MEDIA & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 101 NORTH AMERICA: STERILITY TESTING MEDIA & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 102 EUROPE: STERILITY TESTING MEDIA & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 103 ASIA PACIFIC: STERILITY TESTING MEDIA & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 104 LATIN AMERICA: STERILITY TESTING MEDIA & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 105 MIDDLE EAST: STERILITY TESTING MEDIA & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 106 GCC COUNTRIES: STERILITY TESTING MEDIA & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 107 BIOBURDEN ENUMERATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 108 NORTH AMERICA: BIOBURDEN ENUMERATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 109 EUROPE: BIOBURDEN ENUMERATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 110 ASIA PACIFIC: BIOBURDEN ENUMERATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 111 LATIN AMERICA: BIOBURDEN ENUMERATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 112 MIDDLE EAST: BIOBURDEN ENUMERATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 113 GCC COUNTRIES: BIOBURDEN ENUMERATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 114 OTHER BST ASSAYS, KITS, AND REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 115 NORTH AMERICA: OTHER BST ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 116 EUROPE: OTHER BST ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 117 ASIA PACIFIC: OTHER BST ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 118 LATIN AMERICA: OTHER BST ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 119 MIDDLE EAST: OTHER BST ASSAYS, KITS, AND REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 120 GCC COUNTRIES: OTHER BST ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 121 BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 122 BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 123 NORTH AMERICA: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 124 EUROPE: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 125 ASIA PACIFIC: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 126 LATIN AMERICA: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 127 MIDDLE EAST: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 128 GCC COUNTRIES: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 129 DETECTION & IMAGING SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 130 NORTH AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 131 EUROPE: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 132 ASIA PACIFIC: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 133 LATIN AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 134 MIDDLE EAST: DETECTION & IMAGING SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 135 GCC COUNTRIES: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 136 SEQUENCING INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 137 NORTH AMERICA: SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 138 EUROPE: SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 139 ASIA PACIFIC: SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 140 LATIN AMERICA: SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 141 MIDDLE EAST: SEQUENCING INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 142 GCC COUNTRIES: SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 143 AUTOMATED STERILITY TESTING SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 144 NORTH AMERICA: AUTOMATED STERILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 145 EUROPE: AUTOMATED STERILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 146 ASIA PACIFIC: AUTOMATED STERILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 147 LATIN AMERICA: AUTOMATED STERILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 148 MIDDLE EAST: AUTOMATED STERILITY TESTING SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 149 GCC COUNTRIES: AUTOMATED STERILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 150 OTHER BST INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 151 NORTH AMERICA: OTHER BST INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 152 EUROPE: OTHER BST INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 153 ASIA PACIFIC: OTHER BST INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 154 LATIN AMERICA: OTHER BST INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 155 MIDDLE EAST: OTHER BST INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 156 GCC COUNTRIES: OTHER BST INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 157 BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 158 VIRUS SAFETY TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 159 NORTH AMERICA: VIRUS SAFETY TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 160 EUROPE: VIRUS SAFETY TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 161 ASIA PACIFIC: VIRUS SAFETY TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 162 LATIN AMERICA: VIRUS SAFETY TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 163 MIDDLE EAST: VIRUS SAFETY TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 164 GCC COUNTRIES: VIRUS SAFETY TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 165 STERILITY TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 166 NORTH AMERICA: STERILITY TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 167 EUROPE: STERILITY TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 168 ASIA PACIFIC: STERILITY TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 169 LATIN AMERICA: STERILITY TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 170 MIDDLE EAST: STERILITY TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 171 GCC COUNTRIES: STERILITY TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 172 ENDOTOXIN TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 173 NORTH AMERICA: ENDOTOXIN TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 174 EUROPE: ENDOTOXIN TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 175 ASIA PACIFIC: ENDOTOXIN TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 176 LATIN AMERICA: ENDOTOXIN TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 177 MIDDLE EAST: ENDOTOXIN TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 178 GCC COUNTRIES: ENDOTOXIN TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 179 MYCOPLASMA TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 180 NORTH AMERICA: MYCOPLASMA TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 181 EUROPE: MYCOPLASMA TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 182 ASIA PACIFIC: MYCOPLASMA TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 183 LATIN AMERICA: MYCOPLASMA TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 184 MIDDLE EAST: MYCOPLASMA TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 185 GCC COUNTRIES: MYCOPLASMA TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 186 BIOBURDEN TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 187 NORTH AMERICA: BIOBURDEN TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 188 EUROPE: BIOBURDEN TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 189 ASIA PACIFIC: BIOBURDEN TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 190 LATIN AMERICA: BIOBURDEN TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 191 MIDDLE EAST: BIOBURDEN TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 192 GCC COUNTRIES: BIOBURDEN TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 193 RESIDUAL HCP & DNA DETECTION TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 194 NORTH AMERICA: RESIDUAL HCP & DNA DETECTION TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 195 EUROPE: RESIDUAL HCP & DNA DETECTION TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 196 ASIA PACIFIC: RESIDUAL HCP & DNA DETECTION TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 197 LATIN AMERICA: RESIDUAL HCP & DNA DETECTION TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 198 MIDDLE EAST: RESIDUAL HCP & DNA DETECTION TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 199 GCC COUNTRIES: RESIDUAL HCP & DNA DETECTION TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 200 OTHER TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 201 NORTH AMERICA: OTHER TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 202 EUROPE: OTHER TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 203 ASIA PACIFIC: OTHER TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 204 LATIN AMERICA: OTHER TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 205 MIDDLE EAST: OTHER TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 206 GCC COUNTRIES: OTHER BST TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 207 BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 208 BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & THERAPEUTIC PROTEINS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 209 NORTH AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & THERAPEUTIC PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 210 EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & THERAPEUTIC PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 211 ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & THERAPEUTIC PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 212 LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & THERAPEUTIC PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 213 MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & THERAPEUTIC PROTEINS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 214 GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & THERAPEUTIC PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 215 BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR VACCINES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 216 NORTH AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 217 EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 218 ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 219 LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 220 MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR VACCINES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 221 GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 222 BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR CELLULAR & GENE THERAPY PRODUCTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 223 NORTH AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR CELLULAR & GENE THERAPY PRODUCTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 224 EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR CELLULAR & GENE THERAPY PRODUCTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 225 ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR CELLULAR & GENE THERAPY PRODUCTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 226 LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR CELLULAR & GENE THERAPY PRODUCTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 227 MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR CELLULAR & GENE THERAPY PRODUCTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 228 GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR CELLULAR & GENE THERAPY PRODUCTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 229 BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR BLOOD & BLOOD PRODUCTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 230 NORTH AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR BLOOD & BLOOD PRODUCTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 231 EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR BLOOD & BLOOD PRODUCTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 232 ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR BLOOD & BLOOD PRODUCTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 233 LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR BLOOD & BLOOD PRODUCTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 234 MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR BLOOD & BLOOD PRODUCTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 235 GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR BLOOD & BLOOD PRODUCTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 236 BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 237 NORTH AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 238 EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 239 ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 240 LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 241 MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 242 GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 243 BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 244 BIOLOGICS SAFETY TESTING SERVICES MARKET FOR MONOCLONAL ANTIBODY & THERAPEUTIC PROTEIN SAFETY TESTING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 245 NORTH AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR MONOCLONAL ANTIBODY & THERAPEUTIC PROTEIN, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 246 EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR MONOCLONAL ANTIBODY & THERAPEUTIC PROTEIN SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 247 ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR MONOCLONAL ANTIBODY & THERAPEUTIC PROTEIN SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 248 LATIN AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR MONOCLONAL ANTIBODY & THERAPEUTIC PROTEIN SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 249 MIDDLE EAST: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR MONOCLONAL ANTIBODY & THERAPEUTIC PROTEIN SAFETY TESTING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 250 GCC COUNTRIES: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR MONOCLONAL ANTIBODY & THERAPEUTIC PROTEIN SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 251 BIOLOGICS SAFETY TESTING SERVICES MARKET FOR VACCINE SAFETY TESTING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 252 NORTH AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR VACCINE SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 253 EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR VACCINE SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 254 ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR VACCINE SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 255 LATIN AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR VACCINE SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 256 MIDDLE EAST: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR VACCINE SAFETY TESTING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 257 GCC COUNTRIES: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR VACCINE SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 258 BIOLOGICS SAFETY TESTING SERVICES MARKET FOR CELLULAR & GENE THERAPY SAFETY TESTING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 259 NORTH AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR CELLULAR & GENE THERAPY SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 260 EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR CELLULAR & GENE THERAPY SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 261 ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR CELLULAR & GENE THERAPY SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 262 LATIN AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR CELLULAR & GENE THERAPY SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 263 MIDDLE EAST: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR CELLULAR & GENE THERAPY SAFETY TESTING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 264 GCC COUNTRIES: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR CELLULAR & GENE THERAPY SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 265 BIOLOGICS SAFETY TESTING SERVICES MARKET FOR BLOOD & BLOOD PRODUCT SAFETY TESTING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 266 NORTH AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR BLOOD & BLOOD PRODUCT SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 267 EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR BLOOD & BLOOD PRODUCT SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 268 ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR BLOOD & BLOOD PRODUCT SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 269 LATIN AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET BLOOD & BLOOD PRODUCT SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 270 MIDDLE EAST: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR BLOOD & BLOOD PRODUCT SAFETY TESTING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 271 GCC COUNTRIES: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR BLOOD & BLOOD PRODUCT SAFETY TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 272 BIOLOGICS SAFETY TESTING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 273 NORTH AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 274 EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 275 ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 276 LATIN AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 277 MIDDLE EAST: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 278 GCC COUNTRIES: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 279 BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 280 BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 281 NORTH AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 282 EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 283 ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 284 LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 285 MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 286 GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 287 BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 288 NORTH AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 289 EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 290 ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 291 LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 292 MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 293 GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 294 BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 295 NORTH AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 296 EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 297 ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 298 LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 299 MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 300 GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 301 BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 302 NORTH AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 303 EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 304 ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 305 LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 306 MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 307 GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 308 BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 309 BIOLOGICS SAFETY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 310 NORTH AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 311 EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 312 ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 313 LATIN AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 314 MIDDLE EAST: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 315 GCC COUNTRIES: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 316 BIOLOGICS SAFETY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 317 NORTH AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 318 EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 319 ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 320 LATIN AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 321 MIDDLE EAST: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 322 GCC COUNTRIES: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 323 BIOLOGICS SAFETY TESTING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 324 NORTH AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 325 EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 326 ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 327 LATIN AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 328 MIDDLE EAST: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 329 GCC COUNTRIES: BIOLOGICS SAFETY TESTING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 330 BIOLOGICS SAFETY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 331 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 332 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 333 NORTH AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 334 NORTH AMERICA: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 335 NORTH AMERICA: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 336 NORTH AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 337 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 338 NORTH AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 339 NORTH AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 340 NORTH AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 341 NORTH AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 342 US: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 343 US: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 344 US: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 345 US: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 346 US: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 347 US: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 348 US: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 349 US: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 350 US: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 351 US: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 352 CANADA: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 353 CANADA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 354 CANADA: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 355 CANADA: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 356 CANADA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 357 CANADA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 358 CANADA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 359 CANADA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 360 CANADA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 361 CANADA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 362 EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 363 EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 364 EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 365 EUROPE: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 366 EUROPE: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 367 EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 368 EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 369 EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 370 EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 371 EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 372 EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 373 GERMANY: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 374 GERMANY: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 375 GERMANY: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 376 GERMANY: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 377 GERMANY: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 378 GERMANY: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 379 GERMANY: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 380 GERMANY: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 381 GERMANY: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 382 GERMANY: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 383 UK: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 384 UK: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 385 UK: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 386 UK: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 387 UK: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 388 UK: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 389 UK: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 390 UK: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 391 UK: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 392 UK: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 393 FRANCE: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 394 FRANCE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 395 FRANCE: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 396 FRANCE: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 397 FRANCE: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 398 FRANCE: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 399 FRANCE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 400 FRANCE: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 401 FRANCE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 402 FRANCE: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 403 ITALY: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 404 ITALY: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 405 ITALY: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 406 ITALY: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 407 ITALY: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 408 ITALY: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 409 ITALY: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 410 ITALY: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 411 ITALY: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 412 ITALY: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 413 SPAIN: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 414 SPAIN: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 415 SPAIN: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 416 SPAIN: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 417 SPAIN: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 418 SPAIN: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 419 SPAIN: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 420 SPAIN: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 421 SPAIN: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 422 SPAIN: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 423 REST OF EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 424 REST OF EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 425 REST OF EUROPE: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 426 REST OF EUROPE: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 427 REST OF EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 428 REST OF EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 429 REST OF EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 430 REST OF EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 431 REST OF EUROPE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 432 REST OF EUROPE: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 433 ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 434 ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 435 ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 436 ASIA PACIFIC: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 437 ASIA PACIFIC: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 438 ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 439 ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 440 ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 441 ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 442 ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 443 ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 444 CHINA: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 445 CHINA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 446 CHINA: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 447 CHINA: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 448 CHINA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 449 CHINA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 450 CHINA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 451 CHINA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 452 CHINA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 453 CHINA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 454 JAPAN: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 455 JAPAN: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 456 JAPAN: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 457 JAPAN: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 458 JAPAN: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 459 JAPAN: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 460 JAPAN: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 461 JAPAN: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 462 JAPAN: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 463 JAPAN: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 464 INDIA: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 465 INDIA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 466 INDIA: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 467 INDIA: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 468 INDIA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 469 INDIA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 470 INDIA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 471 INDIA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 472 INDIA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 473 INDIA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 474 SOUTH KOREA: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 475 SOUTH KOREA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 476 SOUTH KOREA: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 477 SOUTH KOREA: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 478 SOUTH KOREA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 479 SOUTH KOREA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 480 SOUTH KOREA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 481 SOUTH KOREA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 482 SOUTH KOREA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 483 SOUTH KOREA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 484 AUSTRALIA: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 485 AUSTRALIA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 486 AUSTRALIA: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 487 AUSTRALIA: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 488 AUSTRALIA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 489 AUSTRALIA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 490 AUSTRALIA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 491 AUSTRALIA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 492 AUSTRALIA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 493 AUSTRALIA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 494 REST OF ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 495 REST OF ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 496 REST OF ASIA PACIFIC: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 497 REST OF ASIA PACIFIC: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 498 REST OF ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 499 REST OF ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 500 REST OF ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 501 REST OF ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 502 REST OF ASIA PACIFIC: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 503 REST OF ASIA PACIFIC: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 504 LATIN AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 505 LATIN AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 506 LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 507 LATIN AMERICA: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 508 LATIN AMERICA: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 509 LATIN AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 510 LATIN AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 511 LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 512 LATIN AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 513 LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 514 LATIN AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 515 BRAZIL: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 516 BRAZIL: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 517 BRAZIL: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 518 BRAZIL: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 519 BRAZIL: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 520 BRAZIL: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 521 BRAZIL: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 522 BRAZIL: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 523 BRAZIL: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 524 BRAZIL: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 525 MEXICO: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 526 MEXICO: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 527 MEXICO: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 528 MEXICO: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 529 MEXICO: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 530 MEXICO: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 531 MEXICO: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 532 MEXICO: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 533 MEXICO: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 534 MEXICO: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 535 REST OF LATIN AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 536 REST OF LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 537 REST OF LATIN AMERICA: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 538 REST OF LATIN AMERICA: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 539 REST OF LATIN AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 540 REST OF LATIN AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 541 REST OF LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 542 REST OF LATIN AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 543 REST OF LATIN AMERICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 544 REST OF LATIN AMERICA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 545 MIDDLE EAST: BIOLOGICS SAFETY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 546 MIDDLE EAST: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 547 MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 548 MIDDLE EAST: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 549 MIDDLE EAST: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 550 MIDDLE EAST: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 551 MIDDLE EAST: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 552 MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 553 MIDDLE EAST: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 554 MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 555 MIDDLE EAST: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 556 GCC COUNTRIES: BIOLOGICS SAFETY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 557 GCC COUNTRIES: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 558 GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 559 GCC COUNTRIES: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 560 GCC COUNTRIES: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 561 GCC COUNTRIES: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 562 GCC COUNTRIES: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 563 GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 564 GCC COUNTRIES: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 565 GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 566 GCC COUNTRIES: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 567 SAUDI ARABIA: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 568 SAUDI ARABIA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 569 SAUDI ARABIA: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 570 SAUDI ARABIA: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 571 SAUDI ARABIA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 572 SAUDI ARABIA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 573 SAUDI ARABIA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 574 SAUDI ARABIA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 575 SAUDI ARABIA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 576 SAUDI ARABIA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 577 UAE: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 578 UAE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 579 UAE: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 580 UAE: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 581 UAE: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 582 UAE: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 583 UAE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 584 UAE: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 585 UAE: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 586 UAE: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 587 REST OF GCC COUNTRIES: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 588 REST OF GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 589 REST OF GCC COUNTRIES: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 590 REST OF GCC COUNTRIES: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 591 REST OF GCC COUNTRIES: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 592 REST OF GCC COUNTRIES: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 593 REST OF GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 594 REST OF GCC COUNTRIES: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 595 REST OF GCC COUNTRIES: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 596 REST OF GCC COUNTRIES: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 597 REST OF MIDDLE EAST: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 598 REST OF MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 599 REST OF MIDDLE EAST: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 600 REST OF MIDDLE EAST: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 601 REST OF MIDDLE EAST: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 602 REST OF MIDDLE EAST: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 603 REST OF MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 604 REST OF MIDDLE EAST: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 605 REST OF MIDDLE EAST: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 606 REST OF MIDDLE EAST: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 607 AFRICA: BIOLOGICS SAFETY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 608 AFRICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 609 AFRICA: BIOLOGICS SAFETY TESTING ASSAYS, KITS, AND REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 610 AFRICA: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 611 AFRICA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 612 AFRICA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
- TABLE 613 AFRICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 614 AFRICA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 615 AFRICA: BIOLOGICS SAFETY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 616 AFRICA: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 617 STRATEGIES ADOPTED BY KEY PLAYERS IN BIOLOGICS SAFETY TESTING MARKET, 2023-2026
- TABLE 618 BIOLOGICS SAFETY TESTING MARKET: DEGREE OF COMPETITION
- TABLE 619 BIOLOGICS SAFETY TESTING MARKET: REGION FOOTPRINT
- TABLE 620 BIOLOGICS SAFETY TESTING MARKET: OFFERING FOOTPRINT
- TABLE 621 BIOLOGICS SAFETY TESTING MARKET: TEST TYPE FOOTPRINT
- TABLE 622 BIOLOGICS SAFETY TESTING MARKET: OFFERINGS APPLICATION FOOTPRINT
- TABLE 623 BIOLOGICS SAFETY TESTING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
- TABLE 624 BIOLOGICS SAFETY TESTING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
- TABLE 625 BIOLOGICS SAFETY TESTING MARKET: PRODUCT LAUNCHES, JANUARY 2023 TO MARCH 2026
- TABLE 626 BIOLOGICS SAFETY TESTING MARKET: DEALS, JANUARY 2023 TO APRIL 2026
- TABLE 627 BIOLOGICS SAFETY TESTING MARKET: EXPANSIONS, JANUARY 2023 TO APRIL 2026
- TABLE 628 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
- TABLE 629 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 630 THERMO FISHER SCIENTIFIC INC: SERVICE LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 631 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023-APRIL 2026
- TABLE 632 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 633 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
- TABLE 634 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 635 CHARLES RIVER LABORATORIES: PRODUCT AND SERVICE LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 636 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2023-APRIL 2026
- TABLE 637 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW
- TABLE 638 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 639 LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS, JANUARY 2023-APRIL 2026
- TABLE 640 LABORATORY CORPORATION OF AMERICA HOLDINGS: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 641 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
- TABLE 642 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 643 F. HOFFMANN-LA ROCHE LTD: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 644 F. HOFFMANN-LA ROCHE LTD: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 645 MERCK KGAA: COMPANY OVERVIEW
- TABLE 646 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 647 MERCK KGAA: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 648 SARTORIUS AG: COMPANY OVERVIEW
- TABLE 649 SARTORIUS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 650 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 651 LONZA: COMPANY OVERVIEW
- TABLE 652 LONZA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 653 LONZA: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 654 LONZA: DEALS, JANUARY 2023-APRIL 2026
- TABLE 655 FUJIFILM CORPORATION: COMPANY OVERVIEW
- TABLE 656 FUJIFILM CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 657 FUJIFILM CORPORATION: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 658 BIOMERIEUX: COMPANY OVERVIEW
- TABLE 659 BIOMERIEUX: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 660 BIOMERIEUX: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 661 BIOMERIEUX: DEALS, JANUARY 2023-APRIL 2026
- TABLE 662 MARAVAI LIFESCIENCES: COMPANY OVERVIEW
- TABLE 663 MARAVAI LIFESCIENCES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 664 MARAVAI LIFESCIENCES: DEALS, JANUARY 2023-APRIL 2026
- TABLE 665 WUXI APPTEC: COMPANY OVERVIEW
- TABLE 666 WUXI APPTEC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 667 SGS SOCIETE GENERALE DE SURVEILLANCE SA: COMPANY OVERVIEW
- TABLE 668 SGS SOCIETE GENERALE DE SURVEILLANCE SA: PRODUCTS/ SERVICES/SOLUTIONS OFFERED
- TABLE 669 SGS SOCIETE GENERALE DE SURVEILLANCE SA: SERVICE LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 670 SGS SOCIETE GENERALE DE SURVEILLANCE SA: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 671 SOTERA HEALTH: COMPANY OVERVIEW
- TABLE 672 SOTERA HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 673 SOTERA HEALTH: SERVICE LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 674 SOTERA HEALTH: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 675 SAMSUNG BIOLOGICS: COMPANY OVERVIEW
- TABLE 676 SAMSUNG BIOLOGICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 677 SAMSUNG BIOLOGICS: DEALS, JANUARY 2023-APRIL 2026
- TABLE 678 SAMSUNG BIOLOGICS: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 679 GENSCRIPT: COMPANY OVERVIEW
- TABLE 680 GENSCRIPT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 681 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
- TABLE 682 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 683 SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW
- TABLE 684 SYNGENE INTERNATIONAL LIMITED: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 685 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
- TABLE 686 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 687 EUROFINS SCIENTIFIC: SERVICE LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 688 EUROFINS SCIENTIFIC: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 689 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
- TABLE 690 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 691 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 692 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023-APRIL 2026
- TABLE 693 QIAGEN: COMPANY OVERVIEW
- TABLE 694 QIAGEN: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 695 QIAGEN: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 696 PROMEGA CORPORATION: COMPANY OVERVIEW
- TABLE 697 CATALENT, INC.: COMPANY OVERVIEW
- TABLE 698 ASSOCIATES OF CAPE COD, INC.: COMPANY OVERVIEW
- TABLE 699 CLEAN BIOLOGICS: COMPANY OVERVIEW
- TABLE 700 PATHOQUEST: COMPANY OVERVIEW
- TABLE 701 PACIFIC BIOLABS: COMPANY OVERVIEW
- TABLE 702 ARL BIO PHARMA, INC.: COMPANY OVERVIEW
- TABLE 703 FRONTAGE LABS: COMPANY OVERVIEW
- TABLE 704 CREATIVE BIOGENE: COMPANY OVERVIEW
- TABLE 705 ADVAXIA BIOLOGICS: COMPANY OVERVIEW
- TABLE 706 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
List of Figures
- FIGURE 1 MARKET SCENARIO
- FIGURE 2 GLOBAL BIOLOGICS SAFETY TESTING MARKET, 2024-2031
- FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BIOLOGICS SAFETY TESTING MARKET, 2023-2026
- FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF BIOLOGICS SAFETY TESTING MARKET
- FIGURE 5 HIGH-GROWTH SEGMENTS IN BIOLOGICS SAFETY TESTING MARKET, 2026-2031
- FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN BIOLOGICS SAFETY TESTING MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
- FIGURE 7 GROWING BIOLOGICS AND BIOSIMILARS PIPELINE TO DRIVE GROWTH IN BIOLOGICS SAFETY TESTING MARKET
- FIGURE 8 SERVICES SEGMENT IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE, BY OFFERING, IN 2025
- FIGURE 9 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
- FIGURE 10 BIOLOGICS SAFETY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 11 BIOLOGICS SAFETY TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
- FIGURE 12 BIOLOGICS SAFETY TESTING MARKET: VALUE CHAIN ANALYSIS
- FIGURE 13 BIOLOGICS SAFETY TESTING MARKET: ECOSYSTEM ANALYSIS
- FIGURE 14 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2023-2025 (USD)
- FIGURE 15 INDICATIVE SELLING PRICE TREND OF KEY PRODUCTS, BY REGION, 2025
- FIGURE 16 BIOLOGICS SAFETY TESTING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- FIGURE 17 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
- FIGURE 18 TOP APPLICANTS/OWNERS (COMPANIES) FOR BIOLOGICS SAFETY TESTING PATENTS, 2015-2025
- FIGURE 19 IMPACT OF AI/GEN AI ON BIOLOGICS SAFETY TESTING MARKET
- FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
- FIGURE 21 KEY BUYING CRITERIA, BY END USER
- FIGURE 22 NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET SNAPSHOT
- FIGURE 23 ASIA PACIFIC: BIOLOGICS SAFETY TESTING MARKET SNAPSHOT
- FIGURE 24 REVENUE ANALYSIS OF KEY PLAYERS, 2021-2025 (USD MILLION)
- FIGURE 25 MARKET SHARE ANALYSIS OF KEY PLAYERS (2025)
- FIGURE 26 BIOLOGICS SAFETY TESTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
- FIGURE 27 BIOLOGICS SAFETY TESTING MARKET: COMPANY FOOTPRINT
- FIGURE 28 BIOLOGICS SAFETY TESTING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
- FIGURE 29 EV/EBITDA OF KEY VENDORS
- FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 31 BIOLOGICS SAFETY TESTING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
- FIGURE 32 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
- FIGURE 33 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2025)
- FIGURE 34 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2025)
- FIGURE 35 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
- FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2025)
- FIGURE 37 SARTORIUS AG: COMPANY SNAPSHOT (2025)
- FIGURE 38 LONZA: COMPANY SNAPSHOT (2025)
- FIGURE 39 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2024)
- FIGURE 40 BIOMERIEUX: COMPANY SNAPSHOT (2025)
- FIGURE 41 MARAVAI LIFESCIENCES: COMPANY SNAPSHOT (2025)
- FIGURE 42 WUXI APPTEC: COMPANY SNAPSHOT
- FIGURE 43 SGS SOCIETE GENERALE DE SURVEILLANCE SA: COMPANY SNAPSHOT (2025)
- FIGURE 44 SOTERA HEALTH: COMPANY SNAPSHOT (2025)
- FIGURE 45 SAMSUNG BIOLOGICS: COMPANY SNAPSHOT (2025)
- FIGURE 46 GENSCRIPT: COMPANY SNAPSHOT (2025)
- FIGURE 47 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 48 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2025)
- FIGURE 49 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025)
- FIGURE 50 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 51 QIAGEN: COMPANY SNAPSHOT (2025)
- FIGURE 52 RESEARCH DESIGN
- FIGURE 53 BIOLOGICS SAFETY TESTING MARKET: BREAKDOWN OF PRIMARIES
- FIGURE 54 BIOLOGICS SAFETY TESTING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
- FIGURE 55 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2025
- FIGURE 56 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC. (2025)
- FIGURE 57 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
- FIGURE 58 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
- FIGURE 59 BIOLOGICS SAFETY TESTING MARKET CAGR PROJECTIONS
- FIGURE 60 DATA TRIANGULATION METHODOLOGY
02-2729-4219
+886-2-2729-4219
生物安全檢測產品與服務市場：2026-2032年全球市場預測，依產品、檢測方法、技術、最終用途及服務類型分類生技藥品安全檢測市場：依產品類型、檢測類型、應用和最終用戶分類－2026-2032年全球市場預測
全球生技藥品安全檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）生物醫學檢測與分析服務市場：依檢測類型、技術、檢體類型、服務模式、檢測方法、最終用戶與應用分類－2026-2032年全球預測
生物製劑安全檢測市場：依產品類型、檢測類型、檢測方式、技術類型及地區劃分 - 趨勢與預測（至2035年）全球生物安全檢測產品和服務市場規模、佔有率、趨勢和成長分析報告（2026-2034年）
全球生物安全檢測產品和服務市場：按產品類型、檢測類型、應用、國家和地區分類－產業分析、市場規模、佔有率和預測（2025-2032年）
生物安全檢測產品和服務市場規模、佔有率和趨勢分析報告：按產品、應用、檢測、地區和細分市場預測（2026-2033 年）
生技藥品安全檢測市場規模、佔有率和成長分析（按產品/服務、檢測類型、應用、最終用戶和地區分類）—產業預測（2026-2033 年）
生物安全檢測市場規模、佔有率及成長分析（按產品類型、檢測類型、應用和地區分類）－2026-2033年產業預測
▼